Boehringer Ingelheim Dethrones Bayer as Germany’s Top Drugmaker

Boehringer Ingelheim GmbH leaped past Bayer AG to become Germany’s largest pharmaceutical company amid rapid growth of its blockbuster medicine for diabetes and heart failure.

The privately held company posted human drug sales of €20.8 billion ($22.1 billion) last year, it said Tuesday. That’s up more than 10% from 2022 and surpassed the €18.1 billion in revenue from Bayer’s pharma division. Boehringer vowed to double down on that progress with a spate of late-stage drug trials planned in the next year and a half, including potential obesity treatments.

Boehringer and Danish research company Zealand Pharma A/S are collaborating on ...